NCT07216313View on ClinicalTrials.gov

A Drug-Drug Interaction Study of Denifanstat and Resmetirom in Healthy Adult Participants

PHASE1Active, not recruitingINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

October 20, 2025

Study Completion Date

October 20, 2025

Conditions

Healthy

Interventions

DRUG

Denifanstat

Once daily

DRUG

Resmetirom

Once daily

Trial Locations (1)

85283

Celerion, Tempe

All Listed Sponsors

lead

Sagimet Biosciences Inc.

INDUSTRY